Published in Curr Opin Gastroenterol on January 01, 2007
Salmonella Typhimurium type III secretion effectors stimulate innate immune responses in cultured epithelial cells. PLoS Pathog (2009) 1.73
Wound healing of intestinal epithelial cells. World J Gastroenterol (2011) 1.35
Potentiation of epithelial innate host responses by intercellular communication. PLoS Pathog (2010) 1.31
Ubiquitin-editing enzyme A20 promotes tolerance to lipopolysaccharide in enterocytes. J Immunol (2009) 1.26
New targets for mucosal healing and therapy in inflammatory bowel diseases. Mucosal Immunol (2013) 1.25
The gut microbiota engages different signaling pathways to induce Duox2 expression in the ileum and colon epithelium. Mucosal Immunol (2014) 0.90
Salmonella modulation of host cell gene expression promotes its intracellular growth. PLoS Pathog (2013) 0.89
Selected commensal-related bacteria and Toll-like receptor 3 agonist combinatorial codes synergistically induce interleukin-12 production by dendritic cells to trigger a T helper type 1 polarizing programme. Immunology (2008) 0.88
Intestinal mucosal tolerance and impact of gut microbiota to mucosal tolerance. Front Microbiol (2015) 0.85
Advanced application of bovine intestinal epithelial cell line for evaluating regulatory effect of lactobacilli against heat-killed enterotoxigenic Escherichia coli-mediated inflammation. BMC Microbiol (2013) 0.85
Detection of Bifidobacterium animalis subsp. lactis (Bb12) in the intestine after feeding of sows and their piglets. Appl Environ Microbiol (2008) 0.84
Regulation of toll-like receptors-mediated inflammation by immunobiotics in bovine intestinal epitheliocytes: role of signaling pathways and negative regulators. Front Immunol (2014) 0.83
The Salmonella Effector Protein SopA Modulates Innate Immune Responses by Targeting TRIM E3 Ligase Family Members. PLoS Pathog (2016) 0.79
Toll-like receptor-induced granulocyte-macrophage colony-stimulating factor secretion is impaired in Crohn's disease by nucleotide oligomerization domain 2-dependent and -independent pathways. Clin Exp Immunol (2008) 0.78
The Subtleties and Contrasts of the LeuO Regulator in Salmonella Typhi: Implications in the Immune Response. Front Immunol (2014) 0.78
CpG-Oligodeoxynucleotide Treatment Protects against Ionizing Radiation-Induced Intestine Injury. PLoS One (2013) 0.78
Increased Expression of Toll-Like Receptors 4, 5, and 9 in Small Bowel Mucosa from Patients with Irritable Bowel Syndrome. Biomed Res Int (2017) 0.75
Advances in the understanding of mitochondrial DNA as a pathogenic factor in inflammatory diseases. F1000Res (2017) 0.75
DNA-fragments are transcytosed across CaCo-2 cells by adsorptive endocytosis and vesicular mediated transport. PLoS One (2013) 0.75
Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology (2004) 6.47
Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature (2005) 5.72
Immunomodulatory functions of type I interferons. Nat Rev Immunol (2012) 3.73
Type IIA topoisomerase inhibition by a new class of antibacterial agents. Nature (2010) 3.58
Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. J Clin Invest (2005) 3.36
Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nat Cell Biol (2006) 3.16
Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: activation of Toll-like receptor 7. Proc Natl Acad Sci U S A (2003) 2.91
Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J Immunol (2004) 2.67
Retracted Induction of a homeostatic circuit in lung tissue by microbial compounds. Immunity (2006) 2.49
Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis. Gastroenterology (2002) 2.19
ERK activation drives intestinal tumorigenesis in Apc(min/+) mice. Nat Med (2010) 2.09
A subset of Toll-like receptor ligands induces cross-presentation by bone marrow-derived dendritic cells. J Immunol (2003) 2.04
Inhibition of experimental asthma by indoleamine 2,3-dioxygenase. J Clin Invest (2004) 1.98
Resolution of airway inflammation following ovalbumin inhalation: comparison of ISS DNA and corticosteroids. Am J Respir Cell Mol Biol (2003) 1.80
An investigation of upper airway changes associated with mandibular advancement device using sleep videofluoroscopy in patients with obstructive sleep apnea. Arch Otolaryngol Head Neck Surg (2009) 1.70
Activation of anti-hepatitis C virus responses via Toll-like receptor 7. Proc Natl Acad Sci U S A (2006) 1.59
Accumulation of peribronchial mast cells in a mouse model of ovalbumin allergen induced chronic airway inflammation: modulation by immunostimulatory DNA sequences. J Immunol (2003) 1.52
Mucosal adjuvant activity of cholera toxin requires Th17 cells and protects against inhalation anthrax. Proc Natl Acad Sci U S A (2010) 1.49
TLR4 signaling in effector CD4+ T cells regulates TCR activation and experimental colitis in mice. J Clin Invest (2010) 1.45
Regulation of dendritic cells and macrophages by an anti-apoptotic cell natural antibody that suppresses TLR responses and inhibits inflammatory arthritis. J Immunol (2009) 1.39
Conventional dendritic cells regulate the outcome of colonic inflammation independently of T cells. Proc Natl Acad Sci U S A (2007) 1.35
IFN-alpha beta promote priming of antigen-specific CD8+ and CD4+ T lymphocytes by immunostimulatory DNA-based vaccines. J Immunol (2002) 1.30
Immunostimulatory DNA inhibits transforming growth factor-beta expression and airway remodeling. Am J Respir Cell Mol Biol (2003) 1.28
Vaccination with irradiated Listeria induces protective T cell immunity. Immunity (2006) 1.23
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis. Proc Natl Acad Sci U S A (2007) 1.20
Interleukin 1 receptor signaling regulates DUBA expression and facilitates Toll-like receptor 9-driven antiinflammatory cytokine production. J Exp Med (2010) 1.18
Autophagy suppresses interleukin-1β (IL-1β) signaling by activation of p62 degradation via lysosomal and proteasomal pathways. J Biol Chem (2011) 1.13
Role of core needle biopsy and ultrasonographic finding in management of indeterminate thyroid nodules. Head Neck (2011) 1.06
Homeostatic effects of TLR9 signaling in experimental colitis. Ann N Y Acad Sci (2006) 1.06
Necessity of oligonucleotide aggregation for toll-like receptor 9 activation. J Biol Chem (2004) 1.04
Immunostimulatory DNA sequences influence the course of adjuvant arthritis. J Immunol (2002) 1.03
Ion channel TRPV1-dependent activation of PTP1B suppresses EGFR-associated intestinal tumorigenesis. J Clin Invest (2014) 1.02
Type I interferons maintain Foxp3 expression and T-regulatory cell functions under inflammatory conditions in mice. Gastroenterology (2012) 1.02
Immunostimulatory DNA inhibits allergen-induced peribronchial angiogenesis in mice. J Allergy Clin Immunol (2006) 1.00
Immunostimulatory oligonucleotides inhibit colonic proinflammatory cytokine production in ulcerative colitis. Inflamm Bowel Dis (2006) 1.00
Do microbes influence the pathogenesis of allergic diseases? Building the case for Toll-like receptor ligands. Curr Opin Immunol (2003) 0.98
Immunostimulatory sequence oligodeoxynucleotide-based vaccination and immunomodulation: two unique but complementary strategies for the treatment of allergic diseases. J Allergy Clin Immunol (2002) 0.97
Divergent requirement for Gαs and cAMP in the differentiation and inflammatory profile of distinct mouse Th subsets. J Clin Invest (2012) 0.95
The mandibular advancement device and patient selection in the treatment of obstructive sleep apnea. Arch Otolaryngol Head Neck Surg (2009) 0.95
Immunostimulatory DNA reverses established allergen-induced airway remodeling. J Immunol (2004) 0.94
Immunostimulatory oligonucleotides attenuate airways remodeling in allergic monkeys. Am J Respir Crit Care Med (2004) 0.93
Signal transducer and activator of transcription 3 (STAT3) protein suppresses adenoma-to-carcinoma transition in Apcmin/+ mice via regulation of Snail-1 (SNAI) protein stability. J Biol Chem (2012) 0.92
TLR9-based immunotherapy for allergic disease. Am J Med (2006) 0.92
The "polarizing-tolerizing" mechanism of intestinal epithelium: its relevance to colonic homeostasis. Semin Immunopathol (2007) 0.88
Antigen-immunostimulatory oligonucleotide conjugates: mechanisms and applications. Immunol Rev (2004) 0.88
Induction of antigen cross-presentation by Toll-like receptors. Springer Semin Immunopathol (2004) 0.88
Suppression of allergic response by CpG motif oligodeoxynucleotide-house-dust mite conjugate in animal model of allergic rhinitis. Am J Rhinol (2006) 0.87
The implication of sleep position in the evaluation of surgical outcomes in obstructive sleep apnea. Otolaryngol Head Neck Surg (2009) 0.87
Early compliance and efficacy of sublingual immunotherapy in patients with allergic rhinitis for house dust mites. Clin Exp Otorhinolaryngol (2009) 0.87
Evaluation of soft palate changes using sleep videofluoroscopy in patients with obstructive sleep apnea. Arch Otolaryngol Head Neck Surg (2009) 0.86
Cigarette smoke promotes eosinophilic inflammation, airway remodeling, and nasal polyps in a murine polyp model. Am J Rhinol Allergy (2014) 0.85
Seasonal Specificity of Seasonal Allergens and Validation of the ARIA Classification in Korea. Allergy Asthma Immunol Res (2012) 0.85
CpG oligonucleotides partially inhibit growth of Mycobacterium tuberculosis, but not Salmonella or Listeria, in human monocyte-derived macrophages. FEMS Immunol Med Microbiol (2005) 0.85
Mouth opening during sleep may be a critical predictor of surgical outcome after uvulopalatopharyngoplasty for obstructive sleep apnea. J Clin Sleep Med (2010) 0.85
Allergen-immunostimulatory oligodeoxynucleotide conjugate: a novel allergoid for immunotherapy. Curr Opin Allergy Clin Immunol (2002) 0.85
Determinants of treatment outcome after use of the mandibular advancement device in patients with obstructive sleep apnea. Arch Otolaryngol Head Neck Surg (2010) 0.85
Molecular and cellular mechanisms of protective immunity to coccidioidomycosis. Vaccine (2005) 0.84
Liposomal immunostimulatory DNA sequence (ISS-ODN): an efficient parenteral and mucosal adjuvant for influenza and hepatitis B vaccines. Vaccine (2002) 0.84
Sunitinib inhibits papillary thyroid carcinoma with RET/PTC rearrangement but not BRAF mutation. Cancer Biol Ther (2011) 0.83
Remodeling associated expression of matrix metalloproteinase 9 but not tissue inhibitor of metalloproteinase 1 in airway epithelium: modulation by immunostimulatory DNA. J Allergy Clin Immunol (2006) 0.83
Allergen-independent immunostimulatory sequence oligodeoxynucleotide therapy attenuates experimental allergic rhinitis. Immunology (2004) 0.83
Clinical implication of the olfactory cleft in patients with chronic rhinosinusitis and olfactory loss. Arch Otolaryngol Head Neck Surg (2009) 0.83
Toll-like receptor ligands: hygiene, atopy and therapeutic implications. Curr Opin Allergy Clin Immunol (2004) 0.82
Ankylosing spondylitis: patterns of radiographic involvement--a re-examination of accepted principles in a cohort of 769 patients. Radiology (2010) 0.81
The therapeutic potential of antigen-oligonucleotide conjugates. Ann N Y Acad Sci (2003) 0.81
DNA-based approaches to the treatment of allergies. Curr Opin Mol Ther (2002) 0.81
Comparison of ciliary wave disorders measured by image analysis and electron microscopy. Acta Otolaryngol (2005) 0.80
Role of hypoxia-inducible factor-1α expression in regulatory T cells on nasal polypogenesis. Laryngoscope (2013) 0.80
Post-tonsillectomy hemorrhage in children: a single surgeon's experience with coblation compared to diathermy. Eur Arch Otorhinolaryngol (2012) 0.79
The Role of Plasmacytoid and Myeloid Dendritic Cells in Induction of Asthma in a Mouse Model and the Effect of a TLR9 Agonist on Dendritic Cells. Allergy Asthma Immunol Res (2011) 0.79
Novel immune function for the TRPV1 channel in T lymphocytes. Channels (Austin) (2014) 0.79
Induction and inhibition of the Th2 phenotype spread: implications for childhood asthma. J Immunol (2005) 0.78
A simple route to difluorocarbene and perfluoroalkylidene complexes of iridium. J Am Chem Soc (2005) 0.78
TLR9 agonist CpG enhances protective nasal HSP60 peptide vaccine efficacy in experimental autoimmune arthritis. Ann Rheum Dis (2012) 0.78
Immunomodulatory effect of tonsil-derived mesenchymal stem cells in a mouse model of allergic rhinitis. Am J Rhinol Allergy (2015) 0.78
Optimized conjugation ratios lead to allergen immunostimulatory oligodeoxynucleotide conjugates with retained immunogenicity and minimal anaphylactogenicity. J Allergy Clin Immunol (2002) 0.78
Retrosternal percutaneous tracheostomy: an approach for predictably impossible classic tracheostomy. Crit Care Res Pract (2010) 0.77
DNA-based vaccines for allergic disease. Expert Rev Vaccines (2002) 0.76
Treatment of postviral olfactory loss with glucocorticoids, Ginkgo biloba, and mometasone nasal spray. Arch Otolaryngol Head Neck Surg (2009) 0.76
Recent advances in immunotherapy of allergic rhinitis. Curr Allergy Asthma Rep (2008) 0.75
Transplantation of neural stem cells in anosmic mice. Clin Exp Otorhinolaryngol (2010) 0.75
A thyroglossal duct cyst causing obstructive sleep apnea in adult. Clin Exp Otorhinolaryngol (2013) 0.75
Change of nasal function with aging in Korean. Acta Otolaryngol Suppl (2007) 0.75
Prognostic factors in oral cavity cancer with skull base recurrence. Auris Nasus Larynx (2010) 0.75
Retraction: DNA-PKcs is required for activation of innate immunity by immunostimulatory DNA. Cell (2009) 0.75
Retraction. Induction of a homeostatic circuit in lung tissue by microbial compounds. Immunity (2008) 0.75
The protective effects of type-1 interferon in models of intestinal inflammation. Adv Exp Med Biol (2009) 0.75
The immediate protective response to microbial challenge. Eur J Immunol (2014) 0.75
Effect of ginkgo biloba and dexamethasone in the treatment of 3-methylindole-induced anosmia mouse model. Am J Rhinol (2008) 0.75
Plasmid DNA encoding the respiratory syncytial virus G protein protects against RSV-induced airway hyperresponsiveness. Vaccine (2002) 0.75